Healthcare
Royalty Pharma plc (RPRX)
Royalty Pharma plc stock analysis and opportunity scoring
$61.41
↑ +0.92%
Royalty Pharma plc (RPRX) at a glance
Royalty Pharma plc (RPRX) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
RPRX last traded at $58.43 as of 2026-09-01.
MKD Intelligence assigns RPRX a composite opportunity score of 69 out of 100, indicating favourable conditions across trend, momentum and volume factors.
The risk score for RPRX is 31 out of 100 (low), where a higher number means greater expected volatility.
Price History
High
$62.07
Low
$56.77
Period
Aug 31 - Jul 31 (22d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 1
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.